Publications

Publications (2011-Present)

1. Skaat A, Solomon A, Moroz I, Hai OV, Rechtman E, Vishnevskia Dai V, Rotenstreich Y. Increased electroretinogram a-wave amplitude after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Acta Ophthalmol. 2011 May;89(3) :e269-73.
2. Kinori M, Pras E, Kolker A, Ferman-Attar G, Moroz I, Moisseiev J, Bandah-Rozenfeld D, Mizrahi-Meissonnier L, Sharon D, Rotenstreich Y. Enhanced S-cone function with preserved rod function: a new clinical phenotype. Mol Vis. 2011;17:2241-7.
3. Estrada-Cuzcano A, Neveling K, Kohl S, Banin E, Rotenstreich Y, Sharon D, Falik-Zaccai TC, Hipp S, Roepman R, Wissinger B, Letteboer SJ, Mans DA, Blokland  EA, Kwint MP, Gijsen SJ, van Huet RA, Collin RW, Scheffer H, Veltman JA, Zrenner  E; European Retinal Disease Consortium, den Hollander AI, Klevering BJ, Cremers FP. Mutations in C8orf37, encoding a ciliary protein, are associated with autosomal-recessive retinal dystrophies with early macular involvement. Am J Hum  Genet. 2012 Jan 13;90(1):102-9.
4. Pras E, Pras E, Reznik-Wolf H, Sharon D, Raivech S, Barkana Y, Abu-Horowitz A, Rotenstreich Y*, Banin E*. Fundus albipunctatus: novel mutations and phenotypic description of Israeli patients. Mol Vis. 2012;18:1712-8. (* Equal Contribution)
5. Skaat A, Sher I, Kolker A, Elyasiv S, Rosenfeld E, Mhajna M, Melamed S, Belkin M, Rotenstreich Y. Pupillometer-based objective chromatic perimetry in normal eyes and patients with retinal photoreceptor dystrophies. Invest Ophthalmol Vis Sci. 2013 Apr 17;54(4):2761-70.
6. Rotenstreich Y, Belkin M, Sadetzki S, Chetrit A, Ferman-Attar G, Sher I, Harari A, Shaish A, Harats D. Treatment With 9- cis β-Carotene-Rich Powder in Patients With Retinitis Pigmentosa: A Randomized Crossover Trial. JAMA Ophthalmol. 2013 May 9:1-8
7. Goldenberg-Cohen N, Banin E, Zalzstein Y, Cohen B, Rotenstreich Y, Rizel L, Basel-Vanagaite L, Ben-Yosef T. Genetic heterogeneity and consanguinity lead to a "double hit": homozygous mutations of MYO7A and PDE6B in a patient with retinitis pigmentosa. Mol Vis. 2013 Jul 20;19:1565-71.
8. Meshi A, Belkin A, Koval T, Kornhouser T, Assia EI, Rotenstreich Y. An Experimental Treatment of Ocular Quinine Toxicity with High-Dose 9-cis Beta-Carotene. Retinal Cases & Brief Reports. 2014; Accepted for publication.
9. Tzameret A, Sher I, Belkin M, Treves A.J,  Meir A, Nagler A, Levkovitch-Verbin H, Barshack I, Rosner M, Rotenstreich Y. Transplantation of human bone marrow mesenchymal stem cells as a thin subretinal layer ameliorates retinal degeneration in a rat model of retinal dystrophy. Exp. Eye Res. 2014 Jan 118: 135-144.
10. Rotenstreich Y, Skaat A, Sher I, Kolker A, Rosenfeld E, Melamed S, Belkin M, Novel technique: a pupillometer-based objective chromatic perimetry. Ophthalmic Technologies XXIV, edited by Fabrice Manns, Per G. Söderberg, Arthur Ho, Proc. SPIE 2014. 8930, Ophthalmic Technologies XXIV, 89300G
11. Rotenstreich Y, Tzameret A, Levi N, Kalish S, Sher I, Zangen A, Belkin M, Repetitive magnetic stimulation improves retinal function in a rat model of retinal dystrophy. Proc. SPIE 2014. 8930, Ophthalmic Technologies XXIV, 893014.
12. van Huet R.A.C, Siemiatkowska A.M, Özgul RK, Hoyng C.B, Banin E, Sharon D, Rotenstreich Y, Theelen T, Collin R.W.J. van den Born , Klevering B.J. Retinitis pigmentosa associated with the ciliary MAK gene is relatively mild and includes no syndromic features. Acta Ophthalmologica 2015 Feb;93(1):83-94.
13. Rotenstreich Y, Tzameret A, Kalish SE, Belkin M, Meir A, Treves AJ, Nagler A, Sher I. A novel system for minimally invasive transplantation of bone marrow derived stem cells as a thin layer in the subretina and extravascular spaces of the choroid for treatment of retinal degeneration. Harefua (in press).
14. Beiderman Y, Belkin M, Rotenstreich Y, Zalevsky Z. Experimental Quantification of the Tactile Spatial Responsivity of Human Cornea. J. Med. Imaging (Accepted for publication) 
15. Levy I, Sher I, Corem-Salkmon E, Ziv O, Meir A, Treves AJ, Nagler A, Kalter-Leibovici O, Margel S, Rotenstreich Y. Bioactive magnetic near Infra-Red fluorescent core-shell iron oxide/human serum albumin nanoparticles for controlled release of growth factors for augmentation of human mesenchymal stem cell growth and differentiation. Journal of Nanobiotechnology.
16. Tzameret A, Sher I, Belkin M, Treves AJ, Meir A, Nagler A, Levkovitch-Verbin H, Rotenstreich Y*, Solomon AS*. (* Equal contribution, Corresponding authors) Epiretinal transplantation of human bone marrow mesenchymal stem cells rescues retinal and vision function in a rat model of retinal degeneration. Stem Cell Res. 2015 Sep;15(2):387-94.
17. Chibel R, Sher I, BenNer D, Mahajna M,  Achiron A, Haj-Yahia S, Skaat A, Berchenko Y,  Oberman B, Kalter-Leibovici O, Freedman L, Rotenstreich Y.  Chromatic multifocal pupillometer for objective perimetry and diagnosis of patients with Retinitis Pigmentosa.  Ophthalmology. 2016 (123):1898-1911
18. Rotenstreich Y, Tzameret A, Kalish SA, Bubis Ettel, Belkin M, Moroz I, Rosner M,  Levy I, Margel S, Sher I. A minimally invasive adjustable-depth blunt injector for delivery of pharmaceuticals into the posterior pole. Acta Ophthalmologica.  (In press)
19. Tzameret A, Kalish SA, Sher I, Meir A, Levy I, Margel S, Moroz I, Rosner M, Treves AJ,  Nagler A, Belkin M, Rotenstreich Y.
    Long term-safety of transplantation of human bone-marrow mesenchymal stem cells in the extravascular spaces of the choroid of rabbits. Stem Cells International (accepted for publication)